Amphastar Pharmaceuticals AMPH Operating margin
Operating margin at other companies
Other financials
Where this comes from
Calculated from Amphastar Pharmaceuticals’s reported figures.
Based on trailing twelve months.
The official record: Amphastar Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Amphastar Pharmaceuticals's operating margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Amphastar Pharmaceuticals's operating margin?
- Amphastar Pharmaceuticals (AMPH) reported operating margin of 16.2% in Q1 2026.
- How has Amphastar Pharmaceuticals's operating margin changed year-over-year?
- Amphastar Pharmaceuticals's operating margin decreased by 39.2% year-over-year, from 26.6% to 16.2%.
- What is the long-term trend for Amphastar Pharmaceuticals's operating margin?
- Over 5 years (2020 to 2025), Amphastar Pharmaceuticals's operating margin has grown at a 44.2% compound annual growth rate (CAGR), from 3.1% to 19.5%.
- What does operating margin mean?
- Operating income as a percentage of revenue (trailing twelve months). Captures profitability from core operations after both cost of revenue and operating expenses, but before interest and taxes.